{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:37:17Z","timestamp":1776742637771,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07903-7","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:05:16Z","timestamp":1773392716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of probiotic supplement on improvement of depressive symptoms in patients with substance-induced depressive disorder: a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Seyed Hamdollah","family":"Mosavat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foroogh","family":"Namjoyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younes","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"3","key":"7903_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1570159X17666191001142934","volume":"18","author":"KV Athira","year":"2020","unstructured":"Athira KV, Bandopadhyay S, Samudrala PK, Naidu VGM, Lahkar M, Chakravarty S. An overview of the heterogeneity of major depressive disorder: current knowledge and future prospective. Curr Neuropharmacol. 2020;18(3):168\u201387.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"7903_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1186\/s12889-023-16477-y","volume":"23","author":"J Prasartpornsirichoke","year":"2023","unstructured":"Prasartpornsirichoke J, Pityaratstian N, Poolvoralaks C, Sirinimnualkul N, Ormtavesub T, Hiranwattana N, et al. The prevalence and economic burden of treatment-resistant depression in Thailand. BMC Public Health. 2023;23(1):1541.","journal-title":"BMC Public Health"},{"issue":"5","key":"7903_CR3","first-page":"300","volume":"3","author":"B Zohuri","year":"2020","unstructured":"Zohuri B, Zadeh S. Global suicide rate among youngsters increasing significantly. J Neur& Br Disord. 2020;3(5):300\u201310.","journal-title":"J Neur& Br Disord"},{"key":"7903_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2020.01.102","volume":"266","author":"K Sanada","year":"2020","unstructured":"Sanada K, Nakajima S, Kurokawa S, Barcel\u00f3-Soler A, Ikuse D, Hirata A, et al. Gut microbiota and major depressive disorder: A systematic review and meta-analysis. J Affect Disord. 2020;266:1\u201313.","journal-title":"J Affect Disord"},{"key":"7903_CR5","doi-asserted-by":"crossref","unstructured":"Huang Y, Shi X, Li Z, Shen Y, Shi X, Wang L, et al. Possible association of firmicutes in the gut microbiota of patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018:3329\u201337.","DOI":"10.2147\/NDT.S188340"},{"key":"7903_CR6","first-page":"45","volume-title":"Gut Microbiome","author":"GA Cresci","year":"2019","unstructured":"Cresci GA, Izzo K. Gut Microbiome. Adult short bowel syndrome: Elsevier; 2019. pp. 45\u201354."},{"key":"7903_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.pmbts.2020.08.012","volume":"176","author":"M Bistoletti","year":"2020","unstructured":"Bistoletti M, Bosi A, Banfi D, Giaroni C, Baj A. The microbiota-gut-brain axis: focus on the fundamental communication pathways. Prog Mol Biol Transl Sci. 2020;176:43\u2013110.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"7903_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57:1\u201324.","journal-title":"Eur J Nutr"},{"key":"7903_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jgh.12294","volume":"28","author":"BS Ramakrishna","year":"2013","unstructured":"Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol. 2013;28:9\u201317.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"7903_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.phrs.2009.11.001","volume":"61","author":"JM Laparra","year":"2010","unstructured":"Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 2010;61(3):219\u201325.","journal-title":"Pharmacol Res"},{"issue":"1","key":"7903_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phrs.2012.09.002","volume":"69","author":"S Bengmark","year":"2013","unstructured":"Bengmark S. Gut microbiota, immune development and function. Pharmacol Res. 2013;69(1):87\u2013113.","journal-title":"Pharmacol Res"},{"key":"7903_CR12","doi-asserted-by":"publisher","first-page":"604179","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch A, Kantsj\u00f6 JB, Ronchi F. The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol. 2020;11:604179.","journal-title":"Front Immunol"},{"issue":"7","key":"7903_CR13","first-page":"1329","volume":"19","author":"T Magrone","year":"2013","unstructured":"Magrone T, Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Design. 2013;19(7):1329\u201342.","journal-title":"Curr Pharm Design"},{"issue":"3","key":"7903_CR14","doi-asserted-by":"publisher","first-page":"1539595","DOI":"10.1080\/21688370.2018.1539595","volume":"6","author":"A Alam","year":"2018","unstructured":"Alam A, Neish A. Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers. 2018;6(3):1539595.","journal-title":"Tissue Barriers"},{"issue":"46","key":"7903_CR15","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","volume":"34","author":"EA Mayer","year":"2014","unstructured":"Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014;34(46):15490\u20136.","journal-title":"J Neurosci"},{"issue":"7","key":"7903_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1037\/amp0000058","volume":"72","author":"RT Liu","year":"2017","unstructured":"Liu RT. The Microbiome as a novel paradigm in studying stress and mental health. Am Psychol. 2017;72(7):655.","journal-title":"Am Psychol"},{"key":"7903_CR17","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s12325-020-01272-7","volume":"37","author":"A Capuco","year":"2020","unstructured":"Capuco A, Urits I, Hasoon J, Chun R, Gerald B, Wang JK, et al. Current perspectives on gut Microbiome dysbiosis and depression. Adv Therapy. 2020;37:1328\u201346.","journal-title":"Adv Therapy"},{"key":"7903_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jad.2016.09.012","volume":"208","author":"D Macedo","year":"2017","unstructured":"Macedo D, Chaves Filho AJM, de Sousa CNS, Quevedo J, Barichello T, J\u00fanior HVN, et al. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord. 2017;208:22\u201332.","journal-title":"J Affect Disord"},{"key":"7903_CR19","doi-asserted-by":"crossref","unstructured":"Alexander C, Ivan U, Jamal H, Chun R, Brittany G, Wang JK, et al. Gut Microbiome dysbiosis and depression: a comprehensive review. Curr Pain Headache Rep. 2020;24(7).","DOI":"10.1007\/s11916-020-00871-x"},{"issue":"11","key":"7903_CR20","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41380-020-0729-1","volume":"25","author":"Z Yang","year":"2020","unstructured":"Yang Z, Li J, Gui X, Shi X, Bao Z, Han H, et al. Updated review of research on the gut microbiota and their relation to depression in animals and human beings. Mol Psychiatry. 2020;25(11):2759\u201372.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7903_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12865-016-0187-3","volume":"18","author":"L Lin","year":"2017","unstructured":"Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18(1):2.","journal-title":"BMC Immunol"},{"key":"7903_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.scitotenv.2018.01.288","volume":"627","author":"L Flandroy","year":"2018","unstructured":"Flandroy L, Poutahidis T, Berg G, Clarke G, Dao M-C, Decaestecker E, et al. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ. 2018;627:1018\u201338.","journal-title":"Sci Total Environ"},{"issue":"5","key":"7903_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/10253890.2019.1617267","volume":"22","author":"N Li","year":"2019","unstructured":"Li N, Wang Q, Wang Y, Sun A, Lin Y, Jin Y, et al. Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis. Stress. 2019;22(5):592\u2013602.","journal-title":"Stress"},{"key":"7903_CR24","doi-asserted-by":"crossref","unstructured":"Cheung SG, Goldenthal AR, Uhlemann A-C, Mann JJ, Miller JM, Sublette ME. Systematic review of gut microbiota and major depression. Front Psychiatry. 2019;10.","DOI":"10.3389\/fpsyt.2019.00034"},{"key":"7903_CR25","doi-asserted-by":"crossref","unstructured":"Calarco CA, Lobo MK. Depression and substance use disorders: Clinical comorbidity and shared neurobiology. International Review of Neurobiology. 157: Elsevier; 2021. pp. 245\u2013309.","DOI":"10.1016\/bs.irn.2020.09.004"},{"key":"7903_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neubiorev.2017.04.001","volume":"77","author":"V Rappeneau","year":"2017","unstructured":"Rappeneau V, B\u00e9rod A. Reconsidering depression as a risk factor for substance use disorder: insights from rodent models. Neurosci Biobehavioral Reviews. 2017;77:303\u201316.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"7903_CR27","doi-asserted-by":"publisher","first-page":"650785","DOI":"10.3389\/fnins.2021.650785","volume":"15","author":"MD Namba","year":"2021","unstructured":"Namba MD, Leyrer-Jackson JM, Nagy EK, Olive MF, Neisewander JL. Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities. Front NeuroSci. 2021;15:650785.","journal-title":"Front NeuroSci"},{"issue":"3","key":"7903_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","volume":"18","author":"A Markou","year":"1998","unstructured":"Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998;18(3):135\u201374.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"7903_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijpsycho.2015.01.011","volume":"98","author":"AR Baskin-Sommers","year":"2015","unstructured":"Baskin-Sommers AR, Foti D. Abnormal reward functioning across substance use disorders and major depressive disorder: considering reward as a transdiagnostic mechanism. Int J Psychophysiol. 2015;98(2):227\u201339.","journal-title":"Int J Psychophysiol"},{"issue":"1","key":"7903_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/10550490701756146","volume":"17","author":"TS Schepis","year":"2008","unstructured":"Schepis TS, Adinoff B, Rao U. Neurobiological processes in adolescent addictive disorders. Am J Addictions. 2008;17(1):6\u201323.","journal-title":"Am J Addictions"},{"key":"7903_CR31","unstructured":"Siemsen BM, Franco D, Lobo MK. Corticostriatal contributions to dysregulated motivated behaviors in stress, depression, and substance use disorders. Neurosci Res. 2022."},{"key":"7903_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev.clinpsy.4.022007.141157","volume":"4","author":"WG Iacono","year":"2008","unstructured":"Iacono WG, Malone SM, McGue M. Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu Rev Clin Psychol. 2008;4:325\u201348.","journal-title":"Annu Rev Clin Psychol"},{"issue":"8","key":"7903_CR33","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2174\/1570159X14666160526120928","volume":"14","author":"J Vlaini\u0126","year":"2016","unstructured":"Vlaini\u0126 J, Suran J, Letizia Vukorep A. Probiotics as an adjuvant therapy in major depressive disorder. Curr Neuropharmacol. 2016;14(8):952\u20138.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"7903_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nut.2015.09.003","volume":"32","author":"G Akkasheh","year":"2016","unstructured":"Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, Jafari P, Akbari H, Taghizadeh M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32(3):315\u201320.","journal-title":"Nutrition"},{"issue":"10","key":"7903_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1080\/01612840.2020.1744203","volume":"41","author":"M Wemrell","year":"2020","unstructured":"Wemrell M, Olsson A, Landgren K. The use of complementary and alternative medicine (CAM) in psychiatric units in Sweden. Issues Ment Health Nurs. 2020;41(10):946\u201357.","journal-title":"Issues Ment Health Nurs"},{"key":"7903_CR36","doi-asserted-by":"crossref","unstructured":"Hashempur MH, Mosavat SH, Heydari M, Shams M. Medicinal plants\u2019 use among patients with dyslipidemia: an Iranian cross-sectional survey. J Complement Integr Med. 2019;16(3).","DOI":"10.1515\/jcim-2018-0101"},{"key":"7903_CR37","doi-asserted-by":"publisher","unstructured":"Chijan MR, Salehi M, Ostovar M, Haghjoo E, Rahimabadi MS, Hashempur MH. The I-CAM-IR: Persian Translation, Cross-Cultural adaptation and revised version of the I-CAM-Q. Traditional Integr Med. 2022;7(4). https:\/\/doi.org\/10.18502\/tim.v7i4.1494.","DOI":"10.18502\/tim.v7i4.1494"},{"key":"7903_CR38","doi-asserted-by":"publisher","first-page":"1206665","DOI":"10.3389\/fpubh.2023.1206665","volume":"11","author":"SH Mosavat","year":"2023","unstructured":"Mosavat SH, Pasalar M, Joulaei H, Ameli V, Heydari ST, Mirzazadeh A, et al. Complementary and alternative medicine use among people living with HIV in Shiraz, Southern Iran. Front Public Health. 2023;11:1206665.","journal-title":"Front Public Health"},{"key":"7903_CR39","doi-asserted-by":"crossref","unstructured":"Yusefi M, Reihani H, Heydari M, Azgomi RND, Hashempur MH. Complementary and alternative medicine use among cancer patients in iran: A systematic review. Prev Med Rep. 2024:102644.","DOI":"10.1016\/j.pmedr.2024.102644"},{"key":"7903_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jad.2019.04.097","volume":"253","author":"B Chahwan","year":"2019","unstructured":"Chahwan B, Kwan S, Isik A, van Hemert S, Burke C, Roberts L. Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. J Affect Disord. 2019;253:317\u201326.","journal-title":"J Affect Disord"},{"key":"7903_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.psyneuen.2017.02.014","volume":"79","author":"A Abildgaard","year":"2017","unstructured":"Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology. 2017;79:40\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"7903_CR42","doi-asserted-by":"crossref","unstructured":"Lange KW, Nakamura Y, Lange KM. The use of probiotics in depression. J Food Bioactives. 2020;12.","DOI":"10.31665\/JFB.2020.13255"},{"issue":"4","key":"7903_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/jcm10040647","volume":"10","author":"VL Nikolova","year":"2021","unstructured":"Nikolova VL, Cleare AJ, Young AH, Stone JM. Updated review and meta-analysis of probiotics for the treatment of clinical depression: adjunctive vs. stand-alone treatment. J Clin Med. 2021;10(4):647.","journal-title":"J Clin Med"},{"key":"7903_CR44","doi-asserted-by":"publisher","first-page":"112568","DOI":"10.1016\/j.psychres.2019.112568","volume":"282","author":"KK Goh","year":"2019","unstructured":"Goh KK, Liu Y-W, Kuo P-H, Chung Y-CE, Lu M-L, Chen C-H. Effect of probiotics on depressive symptoms: A meta-analysis of human studies. Psychiatry Res. 2019;282:112568.","journal-title":"Psychiatry Res"},{"key":"7903_CR45","doi-asserted-by":"crossref","unstructured":"Musazadeh V, Zarezadeh M, Faghfouri AH, Keramati M, Jamilian P, Jamilian P, et al. Probiotics as an effective therapeutic approach in alleviating depression symptoms: an umbrella meta-analysis. Crit Rev Food Sci Nutr. 2022:1\u20139.","DOI":"10.1080\/10408398.2022.2051164"},{"issue":"8","key":"7903_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/nu8080483","volume":"8","author":"R Huang","year":"2016","unstructured":"Huang R, Wang K, Hu J. Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;8(8):483.","journal-title":"Nutrients"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07903-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:43:45Z","timestamp":1776739425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07903-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7903"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07903-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ethical principles and guidelines for research involving human participants. Prior to participation, all individuals provided informed consent after receiving a comprehensive explanation of the study\u2019s purpose, procedures, potential risks and benefits, and their right to withdraw at any time without penalty. The consent process was conducted in a clear and accessible manner, with opportunities for participants to ask questions and receive clarification. All data were handled with strict confidentiality, and participant anonymity was maintained throughout the study. The research protocol was reviewed and approved by Shiraz University of Medical Sciences (IR.SUMS.REC.1400.442) to ensure adherence to ethical standards and the protection of participants\u2019 rights and well-being.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}